Radiation Oncology/Therapy: Page 54

Brainlab acquires reporting software firm Mint Medical

By Erik L. Ridley

Image-guided therapy firm Brainlab has purchased radiology software developer Mint Medical in a deal aimed at broadening its oncology offerings and making radiology reports more automated and data-driven.

March 9, 2021

NorthStar, IBA expand Tc-99m collaboration

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and proton therapy developer Ion Beam Applications (IBA) are expanding their collaboration in an effort to increase the supply of technetium-99m (Tc-99m) around the world.

March 7, 2021

Navidea signs deal for $5M in preferred shares

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with the company's largest shareholder for a private placement of up to $5 million in preferred stock.

March 4, 2021

Mevion installs 1st proton therapy system in Carolinas

By AuntMinnie.com staff writers

Mevion Medical Systems is installing its Mevion S250i proton therapy system at the Levine Cancer Institute at Atrium Health in North Carolina. It will be the first proton therapy system in the Carolinas, Mevion said.

March 4, 2021

RefleXion raises another $40M, mulls Asia strategy

By AuntMinnie.com staff writers

Radiation therapy equipment developer RefleXion Medical has raised another $40 million in financing, a boost for the advancement of the company's biology-guided radiotherapy for cancer.

March 4, 2021

FDA grants EBTATE investigational new drug status

By AuntMinnie.com staff writers

Biotechnology developer Molecular Targeting Technologies has received investigational new drug approval from U.S. Food and Drug Administration (FDA) to study EBTATE use in patients with neuroendocrine tumors.

March 2, 2021

ARTMS gets funds to develop Zr-89 for PET

By AuntMinnie.com staff writers

Canadian radioisotope developer ARTMS has received $300,000 Canadian from Innovate BC to help develop the radioisotope zirconium-89 (Zr-89) for PET for patients who are eligible for immuno-oncology therapies.

March 2, 2021

Varian CEO to step down after Siemens deal

By AuntMinnie.com staff writers

Radiation oncology firm Varian said that its CEO Dow Wilson will be retiring after the company's upcoming acquisition by Siemens Healthineers has been finalized. Chris Toth, Varian's current president and chief operating officer, has been tapped to take over as CEO of Siemens' new Varian business unit.

March 1, 2021

Q BioMed wins Strontium89 supply deal for DOD, VA

By AuntMinnie.com staff writers

Biotech company Q BioMed has landed a contract to supply its Strontium89 metastatic bone cancer palliation radiopharmaceutical to the U.S. Department of Defense (DOD) and the Department of Veterans Affairs (VA).

March 1, 2021

ASTRO lauds Biden's CMS administrator nomination

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) is lauding the Biden administration's nomination of Chiquita Brooks-LaSure as head of the U.S. Centers for Medicare and Medicaid Services (CMS).

February 28, 2021

U.K.'s NICE recommends Sirtex's microsphere for liver cancer

By AuntMinnie.com staff writers

The U.K. National Institute for Health and Care Excellence (NICE) gave radiation oncology firm Sirtex Medical positive guidance on the use of its selection internal radiation therapy with SIR-Spheres yttrium-90 microspheres for the treatment of adults with unresectable advanced hepatocellular carcinoma.

February 25, 2021

COVID-19 vaccine affects imaging results, researchers warn

By Kate Madden Yee

Researchers are warning that the COVID-19 vaccine can manifest on imaging in ways that appear to be disease, according to two studies published February 24 in the American Journal of Roentgenology and Radiology.

February 24, 2021

Previous Page

Page 54 of 464

Next Page